Objective-To show possible alternative uses of the Rashkind ductal umbrella.
Transcatheter occlusion of the arterial duct with a Rashkind umbrella is now a routine procedure in many units. The same technology has been applied to the development of the Lock clamshell device which has been successfully used to close atrial septal defects, both congenital' and iatrogenic,2 and also unoperated muscular ventricular septal defects.3 The clamshell device is not yet available for general use outside North America.
In this report we describe the successful adaptation and use of the Rashkind duct occluder in the management of conditions other than the arterial duct. prudent to defer the elective closure of secundum atrial septal defects until a revised version of the clam-shell device becomes available. These devices have also been used to occlude postoperative,4 and native muscular ventricular septal defects in children before debanding of the pulmonary artery.3 The advantage of avoiding ventriculotomy and shortening the period of cardiopulmonary bypass under these circumstances is obvious. Residual leaking around the device was common in the previous reports and was present to some degree immediately after the procedure in all three of our patients in whom a ductal umbrella was used. All were symptomatically improved, however, and cardiopulmonary bypass was avoided in all. It is also possible that complete closure will ultimately evolve (as in case 8), and the procedure has undoubtedly "brought time" for this to occur in the other two. Furthermore, it may be possible to insert further devices to get complete occlusion. For the time being, however, it is a matter of debate as to whether the avoidance of surgery has outweighed the theoretical risks of the now haemodynamically unimportant residual shunting in our patients. There can be no doubt that rigorous attention to bacterial endocarditis prophylaxis will be required.
Cases 8 and 9 also show the potential for transcatheter closure of perimembranous ventricular septal defects. When there is tricuspid valve tissue around the defect, the device can be deployed without interfering with either atrioventricular or aortic valve function. We do, however, consider transoesophageal echocardiography to be mandatory in the accurate selection of cases and uncomplicated deployment of the device under these circumstances.
In summary, we have shown that the Rashkind ductal umbrella can be successfully used to treat conditions other than the arterial duct. Transoesophageal echocardiography is an important adjunct to the selection of cases and the successful deployment of the device.
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